MK-801 INHIBITS THE DEVELOPMENT OF MORPHINE-TOLERANCE AT SPINAL SITES

被引:85
作者
GUTSTEIN, HB
TRUJILLO, KA
机构
[1] UNIV MICHIGAN, DEPT ANESTHESIOL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA
关键词
OPIATE TOLERANCE; MK-801; SPINAL CORD; ANTINOCICEPTION; TAIL FLICK TEST; NMDA;
D O I
10.1016/0006-8993(93)90597-G
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 has been shown to attenuate tolerance development in rats. In this study, we show that MK-801 inhibits tolerance to the antinociceptive effects of morphine, as assessed by the tail-flick test, in spinalized rats. These results suggest that NMDA receptor antagonists inhibit opiate tolerance at spinal sites, and also provide strong evidence that the effects of MK-801 are not due to its ability to interfere with associative learning, but instead to inhibition of non-associative mechanisms of opiate tolerance.
引用
收藏
页码:332 / 334
页数:3
相关论文
共 17 条
[1]   SPINAL TRANSECTION REDUCES BOTH SPINAL ANTINOCICEPTION AND CNS CONCENTRATION OF SYSTEMICALLY ADMINISTERED MORPHINE IN RATS [J].
ADVOKAT, C ;
GULATI, A .
BRAIN RESEARCH, 1991, 555 (02) :251-258
[2]   THE NMDA RECEPTOR ANTAGONIST-MK-801 PREVENTS LONG-LASTING NONASSOCIATIVE MORPHINE-TOLERANCE IN THE RAT [J].
BENELIYAHU, S ;
MAREK, P ;
VACCARINO, AL ;
MOGIL, JS ;
STERNBERG, WF ;
LIEBESKIND, JC .
BRAIN RESEARCH, 1992, 575 (02) :304-308
[3]   TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF MORPHINE IN THE SPINAL RAT [J].
BERGE, OG ;
HOLE, K .
NEUROPHARMACOLOGY, 1981, 20 (07) :653-657
[4]  
COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
[5]   EXCITATORY AMINO-ACID RECEPTORS AND SYNAPTIC PLASTICITY [J].
COLLINGRIDGE, GL ;
SINGER, W .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (07) :290-296
[6]  
D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[7]  
GUTSTEIN H B, 1992, Anesthesiology (Hagerstown), V77, pA737, DOI 10.1097/00000542-199209001-00737
[8]   BETA-ENDORPHIN PROCESSING AND CELLULAR-ORIGINS IN RAT SPINAL-CORD [J].
GUTSTEIN, HB ;
BRONSTEIN, DM ;
AKIL, H .
PAIN, 1992, 51 (02) :241-247
[9]  
GUTSTEIN HB, 1992, SOC NEUR ABSTR, V18
[10]  
HARRIS LS, 1964, J PHARMACOL EXP THER, V143, P141